Longevity, in the context of healthy ageing, is the ultimate goal of healthcare. It also represents the ground for some of the most significant endpoints in research. Ageing is commonly associated with frailty. However, it can be questioned whether there is room for a "normal frailty", which is the threshold for pathology, and eventually, what is the strategy to integrate assessment and management of frailty, with the aim of increasing life expectancy and quality of life. Muscles, bones and fat deposits count for most of our body weight. The musculoskeletal (MSK) system is central to the understanding, prevention and management of frailty. The role of clinical radiologists is crucial for the benefit of the community, from screening to monitoring the effects of treatments. The aim of this session is to present the current trends and highlights in diagnosing and managing MSK frailty and to discuss how to put them into practice.
Chairperson's introduction
Alberto Bazzocchi, Bologna / Italy
Old and new techniques to assess bone status
Edwin Oei, Rotterdam / Netherlands
The importance of body composition: role of imaging
Maria Pilar Aparisi Gomez, Valencia / Spain
Opportunistic detection of osteoporosis and sarcopenia: a role for AI?
Giorgio Maria Masci, Rome / Italy
Science to practice: strategies for integration
Miriam A Bredella, New York / United States
Panel discussion: Which is the next step for improving clinical practice?